Delivering thymosin β4 and prothymosin α together to injured mouse hearts promoted heart muscle cell division and reduced cardiac dysfunction after a heart attack.
2-peptide cocktailThymosin β4 + prothymosin α together created a permissive environment for cardiomyocyte proliferation and reduced cardiac dysfunction
What the researchers found
Using single-cell RNA sequencing, researchers identified a distinct gene expression profile in the rare cardiomyocytes that enter the cell cycle after myocardial infarction in mice. They found increased DNA synthesis (EdU incorporation) in cardiomyocytes 3 days post-infarction, confirmed by clonal expansion in the border zone of infarcted tissue using multi-color lineage tracing.
Among the enriched genes in proliferating cardiomyocytes, a combination of thymosin β4 (TMSB4) and prothymosin α (PTMA) proved most effective. When delivered therapeutically to the heart wall after ischemic injury, this two-peptide cocktail promoted cardiomyocyte proliferation and attenuated cardiac dysfunction. The study demonstrates that both activating cell division and creating a permissive microenvironment are necessary for cardiac regeneration.
Why it matters
Heart disease is the leading cause of death worldwide, and a heart attack permanently destroys heart muscle because adult cardiomyocytes barely divide. Finding ways to restart heart cell division has been a holy grail of cardiac research. This study is significant because it identifies a specific peptide combination — thymosin β4 and prothymosin α — that promotes heart regeneration in a mammalian model, moving beyond single-factor approaches and showing that creating a supportive environment is as important as triggering cell division itself.
How the study worked
Researchers induced myocardial infarction (heart attacks) in mice and used EdU incorporation and multi-color lineage tracing to identify and track proliferating cardiomyocytes. Single-cell RNA sequencing of cardiomyocytes at 3 days post-injury revealed the transcriptional profile of cycling cells. Candidate genes were tested by combinatorial overexpression in neonatal rat cardiomyocytes and postnatal day 12 mice. The most promising gene combinations were then therapeutically delivered into the myocardial wall of adult mice after ischemic injury to assess regenerative effects.
What this study cannot tell us
This is a preclinical study in mice, and mouse hearts have somewhat greater regenerative capacity than human hearts. The gene delivery approach used (direct myocardial wall injection) would need significant adaptation for clinical use. Long-term outcomes and safety were not assessed. The exact mechanisms by which TMSB4 and PTMA create a permissive environment for proliferation require further investigation. Results in neonatal rat cardiomyocytes and P12 mice may not fully predict adult human responses.
How to read the evidence
This is a well-designed preclinical study using multiple complementary techniques (single-cell sequencing, lineage tracing, gene delivery) in a mouse model. While the evidence is strong for the animal model, no human data exists for this specific therapeutic approach.
When this study was published
Published in 2023, this is a recent study reflecting the current state of cardiac regeneration research and single-cell genomics technology.
The bigger picture
Thymosin β4 has long been studied for its roles in wound healing, inflammation, and tissue repair, but this study adds a new dimension: it can work with prothymosin α to promote heart muscle regeneration. The finding that both cell-autonomous (proliferation signals) and microenvironmental factors are needed for cardiac regeneration could reshape how researchers approach heart repair strategies. It also highlights the value of single-cell genomics in identifying rare cell populations and their therapeutic potential.
Questions still open
- Could thymosin β4 and prothymosin α be delivered non-invasively (e.g., as peptides rather than gene therapy) to achieve similar cardiac regeneration?
- Does this peptide combination promote regeneration in larger animal models with hearts more similar to humans?
- What is the mechanism by which PTMA creates a permissive environment — does it modulate inflammation, extracellular matrix, or immune cell activity in the border zone?
Common questions
Why can't the heart heal itself after a heart attack?
What are thymosin β4 and prothymosin α?
Read the original research
Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice.
Cardiovascular research, 119(3), 802-812
Citation
Gladka, Monika M; Johansen, Anne Katrine Z; van Kampen, Sebastiaan J; Peters, Marijn M C; Molenaar, Bas; Versteeg, Danielle; Kooijman, Lieneke; Zentilin, Lorena; Giacca, Mauro; van Rooij, Eva. (2023). Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice.. Cardiovascular research, 119(3), 802-812. https://doi.org/10.1093/cvr/cvac155